all AI news
AstraZeneca signs a deal worth up to $247M with US-based Absci Corp. to harness Absci's AI tech for large-scale protein analysis to find a viable cancer therapy (Michael Peel/Financial Times)
Dec. 3, 2023, 5:55 a.m. |
Techmeme www.techmeme.com
Michael Peel / Financial Times:
AstraZeneca signs a deal worth up to $247M with US-based Absci Corp. to harness Absci's AI tech for large-scale protein analysis to find a viable cancer therapy — Deal with Absci is the latest between big pharma and tech companies to build new disease treatments
ai tech analysis astrazeneca cancer deal financial harness protein scale tech therapy
More from www.techmeme.com / Techmeme
Jobs in AI, ML, Big Data
Data Architect
@ University of Texas at Austin | Austin, TX
Data ETL Engineer
@ University of Texas at Austin | Austin, TX
Lead GNSS Data Scientist
@ Lurra Systems | Melbourne
Senior Machine Learning Engineer (MLOps)
@ Promaton | Remote, Europe
Intern Large Language Models Planning (f/m/x)
@ BMW Group | Munich, DE
Data Engineer Analytics
@ Meta | Menlo Park, CA | Remote, US